Breast Cancer | Max Hospital
  1. Home
  2. Taxonomy
  3. Breast Cancer

8756 COVID19 positive patients treated across our hospitals till 24th Sept '20

Get Second Opinion

Please provide your phone number with country code

5 + 6 =

Doc Connect

Hospital : 
Max Super Speciality Hospital, Saket
Description: 
  • Robotic Urological Surgery: 15 years journey 
    Dr. Rahul Yadav, Dr. Anant Kumar
  • Robotic surgery is the latest in advanced onco surgical procedures 
    Dr. Harit Chaturvedi
  • Percutaneous balloon aortic valvuloplasty & balloon dilatation of aortic coarctation in a 10 year old child 
    Dr. Neeraj Awasthy, Dr. Sushil Shukla
  • Role of CT/MR imaging and echocardiography in evaluation of valsalva sinus aneurysm 
    Dr. Reena Anand, Dr. Raj Kumar, Dr. Divya Malhotra, Dr. Bharat Aggarwal
  • Risk factors for patients undergoing treatment for Breast Cancer
    Ms. Kanika Arora, Ms. Ritika Samaddar
  • Radiology Case of The Month 
    Dr. Nafisa Shakir Batta, Dr. Dhruv Jain
Date: 
October, 2015 :15
Emergency Call Button

DELHI / NCR : 011-4055 4055

MOHALI : 77107-77107

DEHRADUN : 0135 719 3333

BATHINDA : +91 0164-5212000

 

Bio Medical Waste Report For Shalimar Bagh

Month Red Autoclave(Infected Plastic Waste) Yellow- Incineration(AnatomicalWaste & Soiled Waste) Blue Autoclave (Glass- Bottles) Black Cytotoxic- Incineration( Cytotoxic Contaminated Items) White- Sharp Total Bags Total Weight(In KG's)
  No. of Bags Weight (in KG's) No. of Bags Weight (in KG's) No. of Bags Weight (in KG's) No. of Bags Weight (in KG's) No. of Bags Weight (in KG's)    
Apr-17 924 2963.50 954 2994.10 239 1017.30 103 279.20 1645 606.40 3865 7861.00
May-17 1175 4624.12 1028 3498.40 276 1524.34 87 195.01 1803 823.85 4369 10665.71
Jun-17 1060 4511.45 902 2886.66 293 1324.05 76 194.00 2057 1100.69 4388 10016.85
Jul-17                     0 0.00
Aug-17                     0 0.00
Sep-17                     0 0.00
Oct-17                     0 0.00
Nov-17                     0 0.00
Dec-17                     0 0.00
Jan-18                     0 0.00
Feb-18                     0 0.00
Mar-18                     0 0.00
YTD 3159 12099.065 2884 9379.155 808 3865.69 266 668.705 5505 2530.94 12622 28543.555

Breast Cancer

Home >> Taxonomy >> Breast Cancer

Clinical Directorate

For more info please call 8744 888 888 (Delhi – NCR) & 9988 422 333 (Chandigarh Tri-city), or mail at homecare@maxhealthcare.com

Do you believe these 10 myths about breast cancer? Debunk them NOW

October 16, 2020 0 2 minutes, 44 seconds read

1. Breast cancer can develop only in the elderly

Although the probability of a breast lump turning out to be cancerous is higher in an elderly woman, it is not zero at any age. Breast cancer is known to occur at all ages and even a young girl should visit a specialist and get herself evaluated if she notices a sudden change in the look or feel of her breast.

2. Breast cancer cannot develop during pregnancy and breastfeeding

Most women tend to ignore subtle breast symptoms during pregnancy or while they are breastfeeding, assuming they are ‘normal’ changes. This often proves to be hazardous and can cause a delay in diagnosis. Although breast feeding and early pregnancy reduces a woman’s lifetime risk, cancer can develop in these phases too.

3. Wearing tight, underwired or black bras can cause breast cancer

This is probably one of the most common fake trivia about breast cancer which is often passed on from one lady to another. Your choice of undergarments is very important for your comfort, but it has nothing to do with your risk of developing breast cancer.

4. Deodorants cause breast cancer

Although it has been proposed that the use of underarm deodorants containing aluminium and parabens may be carcinogenic, there is no definite scientific evidence linking the use of deodorants and antiperspirants with increased risk of developing breast cancer.

5. Physical trauma can cause breast cancer

Often patients attribute their breast lump to a physical injury. More often than not, the injury just brings an underlying breast lump to your notice rather than cause the breast lump. Physical trauma can form a hematoma but never breast cancer.

6. Dairy and sugar intake cause breast cancer

Certain studies have shown that milk may be associated with an increased risk of breast cancer because of the hormone content. However, cutting down sugar or dairy intake to zero is not recommended. It is important to understand that moderation is the key. Any imbalanced diet which may lead to weight gain can cause an increased risk of breast cancer mainly if you are postmenopausal.

7. Pain in the breast is a symptom of breast cancer

Ladies often tend to ignore a lump in the breast or nipple discharge if it is not accompanied with pain. It is probably human nature to ignore something which doesn’t give us discomfort, but is very important to know that cancerous lumps are mostly painless.

 8. If you don’t have family history of breast cancer, you are safe from breast cancer

This is absolutely untrue. Only 5-10% of breast cancers are hereditary or familial, most newly diagnosed patients do not report any family history of breast, ovarian or any other cancer.

9. Mammograms prevent breast cancer

A mammogram is basically an X-ray of the breast tissue. It is useful to detect breast cancer at an early stage and if often recommended for women above the age of 40. However, it does not prevent cancer and in fact, may miss certain cancers in younger women.

10. Men can’t get breast cancer

Last but not the least; men can get breast cancer too. Although the incidence of breast cancer in men is much lower, breast cancer is known to occur in men too and can present with a lump or ulcer on their chest.

Related Articles

Featured Doctors

Breast Cancer - It is the Beginning of a Journey rather than the End of the Road

October 12, 2020 0 5 minutes, 26 seconds read

Stage IV Breast Cancer - It’s the Beginning of a Journey rather than the End of the Road

Breast Cancer is the most common cancers in women in India. The numbers are increasing every year. While a part of that can be attributed to increasing life expectancy, a significant blame can be laid upon worsening lifestyle in our population.

When diagnosed in Stages I, II or III, most women with breast cancers can be cured with a combination of treatments that include surgery, radiation, and systemic therapy (chemotherapy, hormonal and in certain cases targeted therapy).

However, the biggest challenge is when a patient is diagnosed with stage IV breast cancer. Stage IV, in simpler terms means that the cancer has already spread from the breast to other organs including liver, lungs, bones, brain etc. There is a limited role for local treatment in this situation. The major back bone of treatment is systemic therapy. Which is chosen as per the breast cancer subtype or disease biology

What to expect when a patient is diagnosed with a Stage IV breast cancer?

The general perception among common people is that stage IV breast cancer is a death sentence with expected life span about a year. There are enough reasons for that to change. There have been tremendous advances in the understanding of the disease leading to emergence of new, more effective treatment options. The average life expectance of these patients is now anywhere between 3 to 4 years. Infact there is a significant percentage of patients who live much longer and succumb to other diseases than cancer.

Are all Stage IV Breast Cancers the same?

All patients diagnosed with breast cancer are subjected to not only a biopsy but also further testing to look at expression of markers like Estrogen Receptor (ER), Progesterone Receptor (PR) and Her 2 receptor. In certain cases, other specialised tests including Next Generation Sequencing (NGS) are also undertaken. This then helps divide breast cancer patients into further subtypes like Hormone Receptor Positive breast Cancers, Her 2 positive Breast cancers and Triple Negative Breast cancers. This means that different treatment options can be offered to patients with Stage IV breast cancer.

How do we treat Hormone Receptor Positive breast Cancers?

These are traditionally the least aggressive subtype of breast cancers.  The thumb rule of treatment is ‘avoid chemotherapy unless absolutely needed”. 

The back bone of treatment is hormonal therapy. Most of the drugs are in the form of oral medications. In the past half a decade or so, at least 5 new medications have emerged showing greater effectiveness in controlling these cancers, with many more in the pipeline. These drugs are not only more effective than the older medications, in many instances they are safer and work for a longer period of time. Typically patients receive a combination of two hormonal drugs in most setting. Chemotherapy is reserved for those patients where there are no further options of hormonal therapy or a very fast response is needed. The average life span is upto 3 to 5 years with the treatment.

How do we treat Her 2 positive Breast Cancers?

The expression of Her 2 Receptors makes these cancers more aggressive. Two decades ago, these patients would generally be treated with chemotherapy alone and results were dismal. It’s the emergence of anti-Her 2 targeted therapy that has brought about a paradigm change in the treatment of these patients. 

What started with one drug called Trastuzumab which showed improvement in survival when combined with traditional chemotherapy, has now expanded into a large portfolio of anti Her 2 drugs that include Trastuzumab, Pertuzumab, Trastuzumab Emtansine, Lapatinib, Neratinib, Tucatinib, Trastuzumab Deruxtecan and others. These drugs, used either alone or in combination with chemotherapy (or now in some cases with oral hormonal therapies) are highly effective and safe. Similar to the Hormone Receptor positive breast cancers , these patient have an average life span of 3 to 4 years.

How do we treat Triple Negative Breast Cancers?

These are the most aggressive subtype of breast cancers being most difficult to control. Traditionally, the only treatment options for these patients have been chemotherapy.

However, that seems to be changing. There is recent data to suggest, that a new class of treatment, called Immunotherapy, has shown promising results for these cancers. These drugs reactivate our body's immune system, own immune cells then kill the cancer cells. Initial studies suggest better outcomes and improvement in survival for selected patients with Triple Negative Breast Cancers.

Another drug that seems to be making waves is the antibody drug conjugate called - Sacituzumab-Govitecan. This drug has shown impressive results in heavily pretreated Triple Negative Breast Cancers and is now being tested in the frontline settings.

There is an impressive array of clinical trials that is evaluating the effectiveness of newer chemotherapy and targeted therapy for these patients.

So what happens when one is diagnosed with stage IV breast Cancer?

The first step is usually a biopsy, with sub typing as discussed earlier, followed in most cases with Whole Body PET CT. On confirmation of diagnosis, subtype and stage, the treating oncologist will typically evaluate the disease pattern, patients’ general condition and fitness and appropriate treatment options are then considered. The case is discussed in a Multi-Disciplinary Tumour Board for optimising treatment choices. Once treatment is started, the first few weeks are spent optimising medications to ensure minimisation of side effects. Most patients undergo a PET CT for disease re evaluation typically 2 to 3 months after initiation of treatment.

Stage IV Breast Cancers are now typically treated like Diabetes or other chronic illnesses. Most patients can expect to be on some medication most of the times. Typically medications are changed when they stop working or give intolerable side effects. Patients can expect to sometimes have a repeat biopsy.

The goals of treatment for Stage IV Breast Cancers are not only longer survival but a good quality of life. That is being achieved not only through more effective medications, but also safer drugs and improvement in supportive care. Most patients will also be under the care of Palliative Care Physician along with a team that comprises of Clinical Psychologist, Dietician, Physiotherapist, Oncology nurse practioner etc.

Conclusions

There have been significant clinically meaningful treatment advances in Stage IV Breast Cancers. The story of these patients now revolves around long survivals, safe and more effective treatments and multi modal team based care. This ensures that the modern patient can go back to her normal life very soon after the diagnosis and treatment initiation. It is indeed, the beginning of a new journey for these patients.

Related Articles

Featured Doctors

Dr. Siddharth Kumar Sahai

Share This: 

Biography

Biographical Sketch: 

Dr. Siddharth Kr. Sahai is a Senior Medical oncologist, trained from all India Institute of medical Sciences (AIIMS), Delhi. He has an experience of 16 + years in managing patients. He has worked and holds teaching experience from most prestigious medical institutions of India like MAMC (Delhi), AIIMS (Delhi) and LHMC (Delhi). Dr. Siddharth Kr. Sahai has rich experience of diagnosing and managing cancer patients. He has in depth knowledge Hormone therapy and Autologus Stem cell Transplant .

PROFESSIONAL JOURNEY

Work Experience: 
  • 16+ years of experience in clinical management of cancer patients
  • 2018 to 2020 – Consultant Medical Oncology , Manipal Hospital , Delhi
  • 2016 to 2018—Senior Consultant , Medical Oncology , Paras Hospital , Gurgaon 
  • 2013 to 2016 – Consultant Medical Oncology FMRI , Gurgaon
Education & Training: 
  • MBBS[MMAMC]
  • MD[MEDICINE]
  • DM[AIIMS]
  • ESMO Certified
Speciality Interest: 
  • Breast Oncology
  • Gynaecological Maligancies (cancer of ovaries, fallopian tubes, uterus, cervix, vagina etc)
  • Head & Neck cancers
  • Targeted Therapy & Immunotherapy
  • Uro-Oncology (Prostate Cancer, Urinary Bladder Cancer, Kidney Cancer etc)
  • Targeted treatment and immunotherapy in lung cancer and sarcoma 
Duration Of OPD: 
  • MAX SUPER SPECIALITY HOSPITAL SHALIMAR BAGH
  • MON TO SATURDAY
  • 9 AM- 5 PM

BREAST CANCER RADIATION THERAPY- JOURNEY FROM 5 WEEKS TO 5 DAYS TREATMENT

October 21, 2019 0 1 minute, 1 second read

Radiation Therapy (RT) for breast cancer has seen a long journey precision and focused therapy. RT is an important part of breast cancer management which improves both local control of cancer as well as patient’s survival.

In earlier times it was a treatment delivered over the span of 5-7 weeks with unavoidable high doses of radiation going to underlying heart and lung.

Now in the era of precision/ focused radiation therapy technique like IGRT and IMRT, in majority patient’s radiation is delivered over 3-4 weeks with much more safety for heart and lung.

In recent years precision of radiation therapy has further improved with several techniques to protect heart and lung with the most important being DIBH (Deep Inspiratory Breath Hold).

In DIBH radiation is delivered in 4D fashion with respiratory gating to keep heart away while delivering radiation therapy.

Further improvement is that in selected patients whole radiation therapy treatment can be delivered over just 4-5 days (rather than weeks) using a technique called APBI (Accelerated Partial Breast Irradiation).

Overall breast cancer radiation therapy has become a much shorter treatment with better safety and precision.

We routinely practice all these advance techniques at department of radiation oncology, Max hospital, Shalimar Bagh.

Related Articles

Featured Doctors

Dr. Aditi Chaturvedi

Memberships: 
  • Indian Society of Oncology (ISO)
  • Indian Association of Surgical Oncology (IASO)
  • European Society of Surgical Oncology (ESSO)
  • Association of Breast Surgeons of India (ABSI)
Share This: 

PROFESSIONAL JOURNEY

Work Experience: 
  • Specialist Surgical Resident Tata Memorial Hospital, Mumbai
  • Specialist Surgical Resident ACTREC, Navi Mumbai
  • Specialist Surgical Resident Homi Bhabha Cancer Hospital, Varanasi
Education & Training: 
  • MBBS Seth GS Medical College & KEM Hospital, Mumbai
  • MS General Surgery AIIMS, New Delhi
  • MCh Surgical Oncology Tata Memorial Hospital, Mumbai
Awards Information: 
  • Gold Medal in General Surgery AIIMS, New Delhi
  • Vice Chancellor’s Certificate of Merit MUHS, Nashik
Speciality Interest: 
  • Breast and Oncoplastic Surgery
  • Women’s health awareness
  • Cancer survivorship
Duration Of OPD: 

     Max Hospital Gurgaon

  • Wednesday 9 AM - 11 AM

       Max Super Speciality Hospital, Saket

  • Monday - 5pm- 6pm
  • Tuesday - 10am to 12am
  • Wednesday - 5pm to 6pm
  • Thursday - 12pm to 2pm
  • Friday  - 8am to 10am
  • Saturday - 10am to 12pm

       Max Institute of Cancer Care-Lajpat Nagar

  • Monday - 9:00 am - 11:00 am

Dr. Neerja Gupta

Share This: 

PROFESSIONAL JOURNEY

Work Experience: 
  • 5 years of breast surgical oncology( 10 years of surgical oncology)
  • Attending Consultant (Surgical Oncology)- Max Hospital, Saket (Feb 2010-Oct 2014)
  • Specialist (General Surgery) – Jaipur Hospital, Punjab (August 2009-Feb2010)
  • Registrar (General Surgery) – BJRM, Delhi (Oct 2006-August 2009 )
Education & Training: 
  • M.S (General Surgery) -Baroda Medical College
  • P.G. certification (breast oncoplasty) - University of East Anglia, U.K
Awards Information: 
  • Max Sewabhav Award-2017
  • Max Gem Award-2015
Speciality Interest: 
  • Breast Surgical oncology
Duration Of OPD: 

  Max Super Speciality Hospital, Patparganj

  • Mon, Wed -4 pm-6 pm
  • Saturday- 2pm-4 pm

  Max Multi Speciality Centre, Noida

  • Wednesday 11 am to 1 pm
  • Saturday - 10 am to 11 am

Dr. Tripti Saxena

Memberships: 
  • European Society for Radiotherapy and Oncology (ESTRO)
  • Association of Radiation Oncology of India (AROI)
  • Indian Medical Association
  • Oncology Forum
     

View other oncologists in Delhi.

Share This: 

Biography

Biographical Sketch: 
  • Dr. Tripti is a Radiation Oncologist whose clinical practice is primarily focused on Breast & Thoracic Cancers. She is trained in IMRT, IGRT, SBRT, SRS and Brachytherapy from SGPGI, AIIMS and MSKCC New York & have expertise in using all the most modern forms of radiation.

PROFESSIONAL JOURNEY

Work Experience: 
  • Associate Consultant - Max Super Speciality Hospital, Patparganj
  • Attending Consultant - Max Super Speciality Hospital, Patparganj
  • Senior Registrar - SGPGI, Lucknow
  • Senior Registrar - AIIMS, New Delhi
  • Ex-observer - MSKCC, New York
     
Education & Training: 
  • MBBS - MKCG Medical College, Berhampur University, Orissa
  • MD - GSVM Medical College, Kanpur, UP
     
Awards Information: 
  • Best Performance Certificate in MD/MS Examination conducted by Kanpur University
     
Speciality Interest: 
  • Breast and Thoracic Oncology
  • IMRT, IGRT, VMAT, SBRT, SRS
  • Motion Management in Radiation Therapy esp Respiratory Gating and DIBH
  • Brachytherapy
     
Duration Of OPD: 

      Max Super Speciality Hospital, Patparganj

  • Tuesday to Friday: 1 PM – 4 PM

       Max Multi Speciality Centre, Noida

  • Tuesday, Thursady-11 am to 1pm
Book an Appointment